Your browser doesn't support javascript.
loading
Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.
Dayakar, Alti; Shanmukha, Kumar D; Kalangi, Suresh K.
Afiliação
  • Dayakar A; Independent Researcher, Vizianagaram, India.
  • Shanmukha KD; Institut für Experimentelle Kardiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld- 669, 69120, Heidelberg, Germany.
  • Kalangi SK; Amity Stem cell Institute, Amity Medical School, Amity University Haryana, Amity Education Valley Pachgaon, Manesar, Gurugram, HR, 122413, India. skkalangi@ggn.amity.edu.
Mol Biol Rep ; 49(7): 6827-6846, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35031927
ABSTRACT
Till date, several groups have studied the mechanism of microRNA (miRNA) biogenesis, processing, stability, silencing, and their dysregulation in cancer. The miRNA coding genes recurrently go through abnormal amplification, deletion, transcription, and epigenetic regulation in cancer. Some miRNAs function as tumor promoters while few others are tumor suppressors based on the transcriptional regulation of target genes. A review of miRNAs and their target genes in a wide range of cancers is attempted in this article, which may help in the development of new diagnostic tools and intervention therapies. The contribution of miRNAs for drug sensitivity or resistance in cancer therapy and opportunities of miRNAs in cancer prognosis or diagnosis and therapy is also presented in detail.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article